Cancer Drug Assessment “Too Long”

An NHS watchdog is taking too long to assess cancer drugs which could potentially save lives, a charity says. CancerBACUP warned patients could die waiting for the National Institute for Health and Clinical Excellence (Nice) to complete deliberations. The charity is concerned that budget cuts, which have forced the closure of one of the three appraisal committees, will further slow the process.